Key Metrics
CiteScore 

7.7
Eigenfactor 

0.005 - 0.01
Impact Factor 

5 - 10
Scite Index 

0.91 5-Year SI

SNIP 

1.26
Recommended pre-submission checks
Powered by 

Topics Covered on Hepatology Communications
Hepatology Communications Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | JOHN WILEY & SONS LTD |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 2700 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Association for the Study of Liver Diseases |
| Frequency | Monthly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 8 |
| Waiver Policy | Visit website |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Hepatology Communications ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Hepatology Communications
Challenges in the care of rare vascular liver diseases: Insights from patients, health care providers, and patient organizations.
- 1 Sep 2026
- Hepatology communications
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.
- 1 Sep 2026
- Hepatology communications
Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining.
- 1 Sep 2026
- Hepatology communications
Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds.
- 1 Sep 2026
- Hepatology communications
Contemporary global epidemiology of cirrhosis.
- 1 Aug 2026
- Hepatology communications
Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis.
- 1 Aug 2026
- Hepatology communications
Challenges in the care of rare vascular liver diseases: Insights from patients, health care providers, and patient organizations.
- 1 Sep 2026
- Hepatology communications
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.
- 1 Sep 2026
- Hepatology communications
Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining.
- 1 Sep 2026
- Hepatology communications
Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds.
- 1 Sep 2026
- Hepatology communications
Contemporary global epidemiology of cirrhosis.
- 1 Aug 2026
- Hepatology communications
Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis.
- 1 Aug 2026
- Hepatology communications